GlassScriptPhysician profile
Robert Burgmeier
NPI 1407247331
$60,356.12
in general payments reported to CMS, 2019-2025
21 companies · $798 in 2025
The $798 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $27K · 2021: $15K · 2022: $16K · 2023: $86.22 · 2024: $530 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129 · Travel and Lodging: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.95 |
| Travel and Lodging | $285.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $29,099.72 | 2020-2022 | |
| Smith+Nephew, INC. | $12,848.84 | 2020-2024 | Cadence, Uni Cp, Salto Talaris Total Ankle Prosthesis |
| Pylant Medical | $12,609.07 | 2021-2025 | |
| Stryker Corporation | $2,204.37 | 2020-2025 | Alphavent, Pangea, Aequalis Ascend Flex |
| Southern Edge Orthopaedics, INC. | $1,953.10 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $729.60 | 2019 | |
| Depuy Synthes Sales INC. | $196.91 | 2021-2025 | Na, Monovisc, Orthovisc |
| Linvatec Corporation | $111.97 | 2022-2024 | Biobrace 23mm, Allograft Tissue, Hercules |
| Ferring Pharmaceuticals INC. | $99.35 | 2023-2025 | Euflexxa |
| Skeletal Dynamics INC | $98.35 | 2024 | Implate, Geminus, Ijs |
| Foundation Fusion Solutions, LLC | $61.77 | 2024 | |
| Theragen, INC. | $58.67 | 2022 | |
| Avanos Medical | $51.38 | 2021-2022 | |
| Trimed, INC. | $47.95 | 2025 | |
| Bioventus LLC | $46.61 | 2025 | Exogen Ultrasound Bone Healing System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $32.82 | 2022-2025 | Maci |
| Vertex Pharmaceuticals Incorporated | $28.39 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.37 | 2023 | Iovera |
| Globus Medical, INC. | $21.50 | 2024 | Precice Intramedullary Limb Lengthening System |
| Orthofix Medical, INC. | $16.29 | 2022 | |
| Horizon Therapeutics Plc | $15.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Burgmeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.